Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a five year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry
11/06/2018
Carretero G, Ferrándiz G, Daudén E, Vanaclocha F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina M, López-Estebaranz JL, Ferrán M, Torrado R, Carrascosa JM, Carazo C, Rivera R, Jiménez-Puya R, et al
Descargar documento
J Eur Acad Dermatol Venereol. 2015 Jan;29(1):156-63 PMID: 24684267